Qilong Chen
- Molecular Biology top 10%
- Oncology top 10%
- Pharmacology top 1%
- Surgery top 10%
- Pulmonary and Respiratory Medicine top 10%
- Topics
- Liver Disease Diagnosis and Treatment (18 papers)Pancreatic and Hepatic Oncology Research (13 papers)MicroRNA in disease regulation (11 papers)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Qilong Chen
115 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 134
- Molecular Biology 920
- Oncology 396
- Pharmacology 358
- Surgery 301
- Pulmonary and Respiratory Medicine 290
Countries citing papers authored by Qilong Chen
This map shows the geographic impact of Qilong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qilong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qilong Chen more than expected).
Fields of papers citing papers by Qilong Chen
This network shows the impact of papers produced by Qilong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qilong Chen. The network helps show where Qilong Chen may publish in the future.
Co-authorship network of co-authors of Qilong Chen
This figure shows the co-authorship network connecting the top 25 collaborators of Qilong Chen. A scholar is included among the top collaborators of Qilong Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qilong Chen. Qilong Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 9 | |
| 3 | 4 | |
| 4 | 5 | |
| 5 | 1 | |
| 6 | 0 | |
| 7 | 14 | |
| 8 | 8 | |
| 9 | 11 | |
| 10 | 2 | |
| 11 | 2 | |
| 12 | 7 | |
| 13 | 1 | |
| 14 | 61 | |
| 15 | 13 | |
| 16 | 15 | |
| 17 | 93 | |
| 18 | 240 | |
| 19 | 41 | |
| 20 | Characteristics and tectonic setting of the Tula aluminous A-type granite at the south side of the Altyn Tagh fault, NW China | 11 |
About Qilong Chen
Qilong Chen is a scholar working on Hepatology, Pharmacology and Complementary and alternative medicine, having authored 120 papers that have together received 2.4k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (18 papers), Pancreatic and Hepatic Oncology Research (13 papers) and MicroRNA in disease regulation (11 papers). The work is most often cited by research in Pharmacology (358 citations), Complementary and alternative medicine (219 citations) and Hepatology (181 citations). Qilong Chen has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Shi-Bing Su, Yi-Yu Lu, Qing‐Ya Li, Qianmei Zhou, Hui Zhang, Sai Wang, Yiyang Dong, Jiahui Liu, Cailai Wu and Wei Peng Yong. Their work appears in journals such as Journal of Clinical Investigation, Nature Communications and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.